Title
Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors
Authoring Organization
Publication Month/Year
January 22, 2018
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
To systematically review and update the 2013 guideline to affirm its validity; to assess the evidence of new genetic discoveries, technologies, and therapies; and to issue an evidence-based update.
Inclusion Criteria
Female, Male, Adult
Health Care Settings
Hospital, Outpatient
Intended Users
Laboratory technician, genetics, nurse, nurse practitioner, physician, physician assistant
Scope
Management, Treatment
Diseases/Conditions (MeSH)
D008175 - Lung Neoplasms
Keywords
Targeted Tyrosine Kinase Inhibitors, Lung cancer treatment
Supplemental Methodology Resources
Methodology
Number of Source Documents
157
Literature Search Start Date
January 1, 2012
Literature Search End Date
May 17, 2015